After attending the International Cannabis Business Conference (ICBC) in Berlin at the end of April, I was reminded, yet again, of how draconian U.S. marijuana laws truly are. The excitement throughout the event was palpable. Much of it was driven by Germany’s newly formed government keeping its quasi-legalization policy intact, even if adult-use trials remain
Our cannabis business attorneys regularly handle transactions involving the purchase and sale of licensed cannabis businesses. These deals often move fast, with brokers rushing both sides toward closing—frequently without regard for applicable diligence and cannabis regulations. The worst-case scenario is when a company comes to us after executing a seller drafted purchase agreement without having
On Thursday, November 7th, Vince Sliwoski and Fred Rocafort held a post election discussion “Post-Election Cannabis Wrap – Smoke ’em if You’ve Got ’em”. Watch the replay! Key Takeaways from the “Smoke ’em if You’ve Got ’em – 2024 Post Election Cannabis Wrap” Webinar: Panelists: Vince Sliwoski: Oregon Business lawyer specializing in cannabis and commercial
Last Thursday, we learned that the DEA’s marijuana rescheduling hearings are delayed until early next year. We also saw the list of 25 participants invited by the DEA to testify at those hearings. The takeaways here are: a) we will not have a substantive hearing on marijuana rescheduling until a new President takes office, and
Election Day is next Tuesday, November 5. I have plenty of thoughts! Today I’ll stay in my lane, though, and focus on the cannabis state ballot measures. The voting states this time around include Florida, Nebraska, North Dakota and South Dakota. I’m aware of one other jurisdiction is doing work around the edges– namely, Oregon’s
In case you haven’t heard, the Drug Enforcement Administration (DEA) wants to hear from you on marijuana rescheduling. Specifically, DEA invites your comments on its notice of proposed rulemaking (NPRM) to move both marijuana and marijuana extract from schedule I to schedule III of the federal Controlled Substances Act (CSA). The comment submission deadline is
As California continues to pioneer in the cannabis industry, a new trend is taking the scene by storm: cannabis consumption lounges. These lounges are becoming the ultimate hangout spots, and the latest buzz is about adding food and non-alcoholic drinks to the menu. Let’s dive into what’s happening with consumption lounges in California and how
Marijuana-specific controls in schedule III? The Drug Enforcement Administration (DEA) published its Notice of Proposed Rulemaking (“NOPR”) last week to much fanfare. The NOPR would reschedule marijuana, “marijuana extract” and “naturally derived delta-9 tetrahydrocannabinols” from schedule I to schedule III of the Controlled Substances Act (CSA). But that’s not all. In my very quick analysis
As the 2024 elections draw near, the economic impact of cannabis legalization will likely become a prominent topic in political discourse. With billions in total sales, and millions in tax revenue, the economic benefits of legal cannabis are clear. Beyond the monetary gains, there is a crucial aspect of the cannabis industry that should not
Today is another historic day in the history of cannabis control and regulation. In a much anticipated announcement, the Drug Enforcement Administration (DEA) issued a notice of proposed rulemaking to reschedule marijuana, from Controlled Substances Act (CSA) schedule I to schedule III (the “Proposed Rule”). We have covered the implications of a schedule III placement
